Respiratory Syncytial Virus (RSV) Vaccine Clinical Research Study in Canoga Park

The Respiratory Syncytial Virus, also known as RSV, is a virus that can cause mild, cold-like symptoms. However, many groups of people are at higher risk of becoming hospitalized due to the Respiratory Syncytial Virus or even dying. If you are one of the people who are at high-risk for the Respiratory Syncytial Virus or are otherwise interested in learning more about the RSV vaccine, a Respiratory Syncytial Virus (RSV) Vaccine Clinical Research Study in Canoga Park is happening now.

What Is The Respiratory Syncytial Virus?

According to the CDC, the Respiratory Syncytial Virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs) in children younger than one year of age in the United States.

Examples of severe infections include:

• Bronchiolitis (an inflammation of the small airways in the lung)
• Pneumonia
• Worsening of chronic health problems, such as asthma or congestive heart failure

Individuals with a high risk of complications due to RSV include:

• Older adults, especially those 60 years and older
• Adults with chronic heart or lung disease
• Adults with weakened immune systems
• Infants and young children

Is The Respiratory Syncytial Virus (RSV) Vaccine Clinical Research Study Safe?

This professional clinical study, conducted by Clinical Research LA, is a short-term trial in which you will take a vaccine seeking FDA approval. Phase 1 study included human participants and saw limited adverse reaction issues. This clinical research study is a phase 2 study which means that the Phase 1 study was very promising, and the FDA has approved the study to move to phase 2.

Here is what you can expect:

• Complimentary consultation and health exam
• Complimentary lab reports
• Meets all industry safety guidelines
• Governed & monitored by a central ethics committee
• Free transportation or travel reimbursement
• FDA-Governed
• HIPAA-compliant
• Full confidentiality
• Guaranteed compensation

RSV Vaccine Study at Clinical Research LA

Our clinical research clinic has extensive experience conducting Phase II through IV clinical trials with many leading pharmaceutical companies. The facility conducting the Respiratory Syncytial Virus (RSV) Vaccine Clinical Research Study in Canoga Park features multiple investigators with many years in clinical research and counts over 10,000 patients. Every team member offers a wealth of experience, a caring personality, and a commitment to ably serving the pharmaceutical industry, the community, and its patients.

To volunteer as a participant for the RSV Vaccine Study in Canoga Park, or to see a list of other open studies currently accepting participants, visit our website. After contacting us by calling us at 1-866-734-2060, the program will be carefully explained by our professional medical team. You will then be asked to come in for a free medical evaluation to determine if you are suitable for the study — no insurance, social security card, or proof of citizenship is required.